Cargando…
Non-CYP2D6 Variants Selected by a GWAS Improve the Prediction of Impaired Tamoxifen Metabolism in Patients with Breast Cancer
A certain minimum plasma concentration of (Z)-endoxifen is presumably required for breast cancer patients to benefit from tamoxifen therapy. In this study, we searched for DNA variants that could aid in the prediction of risk for insufficient (Z)-endoxifen exposure. A metabolic ratio (MR) correspond...
Autores principales: | Hennig, Ewa E., Piątkowska, Magdalena, Goryca, Krzysztof, Pośpiech, Ewelina, Paziewska, Agnieszka, Karczmarski, Jakub, Kluska, Anna, Brewczyńska, Elżbieta, Ostrowski, Jerzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722498/ https://www.ncbi.nlm.nih.gov/pubmed/31344832 http://dx.doi.org/10.3390/jcm8081087 |
Ejemplares similares
-
Limited predictive value of achieving beneficial plasma (Z)-endoxifen threshold level by CYP2D6 genotyping in tamoxifen-treated Polish women with breast cancer
por: Hennig, Ewa E., et al.
Publicado: (2015) -
GWAS Links New Variant in Long Non-Coding RNA LINC02006 with Colorectal Cancer Susceptibility
por: Hennig, Ewa E., et al.
Publicado: (2021) -
Common functional alterations identified in blood transcriptome of autoimmune cholestatic liver and inflammatory bowel diseases
por: Ostrowski, Jerzy, et al.
Publicado: (2019) -
Combination Testing Using a Single MSH5 Variant alongside HLA Haplotypes Improves the Sensitivity of Predicting Coeliac Disease Risk in the Polish Population
por: Paziewska, Agnieszka, et al.
Publicado: (2015) -
Mitochondrial-related proteomic changes during obesity and fasting in mice are greater in the liver than skeletal muscles
por: Nesteruk, Monika, et al.
Publicado: (2013)